Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Times Interest Earned (2016 - 2024)

Sunshine Biopharma's Times Interest Earned history spans 11 years, with the latest figure at -$238.92 for Q4 2024.

  • For Q4 2024, Times Interest Earned fell 505.93% year-over-year to -$238.92; the TTM value through Sep 2025 reached -$759.14, down 1129.11%, while the annual FY2024 figure was -$662.43, 1800.74% down from the prior year.
  • Times Interest Earned reached -$238.92 in Q4 2024 per SBFM's latest filing, up from -$5176.6 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.99 in Q2 2021 to a low of -$858990.0 in Q3 2022.
  • Average Times Interest Earned over 5 years is -$48104.3, with a median of -$26.56 recorded in 2024.
  • Peak YoY movement for Times Interest Earned: crashed 8109137.82% in 2022, then soared 100.0% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at -$3.26 in 2020, then crashed by 134.44% to -$7.63 in 2021, then crashed by 11429.02% to -$880.12 in 2022, then soared by 95.52% to -$39.43 in 2023, then crashed by 505.93% to -$238.92 in 2024.
  • Per Business Quant, the three most recent readings for SBFM's Times Interest Earned are -$238.92 (Q4 2024), -$5176.6 (Q2 2024), and -$27.46 (Q1 2024).